MedTrace Logo

Single Pass Albumin Dialysis in Patients With Cirrhosis

NCT00764049 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2015-02-25

No results posted yet for this study

Summary

The aim of this study is to determine whether a simplified device of albumin dialysis also has beneficial effects.

Conditions

  • Cirrhosis
  • Acute on Chronic Hepatic Failure
  • Hepatorenal Syndrome
  • Encephalopathy

Interventions

DEVICE

Single pass albumin dialysis

6 hours sessions of albumin dialysis.

Sponsors & Collaborators

  • Laboratoire français de Fractionnement et de Biotechnologies

    collaborator INDUSTRY

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • François Durand, Pr · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2012-01-31
Completion
2012-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00764049 on ClinicalTrials.gov